Participants Are Needed For The "Assessing The Knowledge of Gene Therapy As A Treatment Option In The Sickle Cell Disease Population" Research Study
Sickle Cell Advocates Affirm Support for Drug Development Following the Discontinuation of Pfizer’s THRIVE-131 Trial
Comments